Apple extracts attenuate tumor necrosis factor-α-induced nuclear factor-κB activation by inhibiting IκB kinase and proteasome in A549 human non-small lung carcinoma cells

Food Science and Biotechnology

Volumn 21, Issue 4, 2012, Pages 1203-1208

  Cho, Woo Ree ^a   Yoon, Hyungeun ^a  

^a Sungshin Women's University   (South Korea)

Author keywords

A549; apple; lung cancer; NF B; proteasome

Indexed keywords

A549; A549 CELLS; APPLE; CHRONIC DISEASE; HEALTH BENEFITS; HUMAN LUNG CANCER CELLS; LUNG CANCER; LUNG CANCER CELLS; LUNG CARCINOMA; NUCLEAR FACTORS; PHYTOCHEMICALS; PROTEASOMES; TUMOR NECROSIS FACTORS;

BIOLOGICAL ORGANS; CELL PROLIFERATION; DISEASES; ENZYMES; GLYCOPROTEINS; MACROPHAGES; PHOSPHORYLATION;

FRUITS;

MALUS X DOMESTICA;

EID: 84866069765     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10068-012-0157-3     Document Type: Article

References (49)

1. Miniño AM. Death in the United States, 2009. NCHS Data Brief. 64 National Center for Health Statistics, Hyattsville, MD, USA (2011).
2. ACS. Cancer Facts & Figures 2012. American Cancer Society, Atlanta, GA, USA (2012).
3. Bours V, Bentires-Alj M, Hellin A, Viatour P, Robe P, Delhalle S, Benoit V, Merville M. Nuclear factor-κB, cancer, and apoptosis. Biochem. Pharmacol. 60: 1085-1090 (2000).
4. Sun Z, Andersson R. NF-κB activation and inhibition: A review. Shock 18: 99-106 (2002).
5. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 71: 1397-1421 (2006).
6. van Waes C. Nuclear factor-κB in development, prevention, and therapy of cancer. Clin. Cancer Res. 13: 1076-1082 (2007).
7. Nakshatri H, Goulet RJ. NF-κB and breast cancer. Curr. Prob. Cancer 26: 282-309 (2002).
8. Wu JT, Kral JG. The NF-κB/IκB signaling system: A molecular target in breast cancer therapy. J. Surg. Res. 123: 158-169 (2005).
9. Willett WC. Diet and health: What should we eat? Science 264: 532-537 (1994).
10. Willett WC. Balancing life-style and genomics research for disease prevention. Science 296: 695-698 (2002).
11. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr. Cancer 18: 1-29 (1992).
12. Liu RH. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am. J. Clin. Nutr. 78: 517S-520S (2003).
13. Liu RH. Potential synergy of phytochemicals in cancer prevention: Mechanism of action. J. Nutr. 134: 3479S-3485S (2004).
14. Dias AS, Porawski M, Alonso M, Marroni N, Collado PS, Gonzalez-Gallego J. Quercetin decreases oxidative stress, NF-κB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J. Nutr. 135: 2299-2304 (2005).
15. Natarajan K, Manna SK, Chaturvedi MM, Aggarwal BB. Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-κB, degradation of IκBα, nuclear translocation of p65, and subsequent gene expression. Arch. Biochem. Biophys. 352: 59-70 (1998).
16. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation. Mol. Pharmacol. 69: 195-206 (2006).
17. Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem. Pharmacol. 70: 700-713 (2005).
18. Joe AK, Liu H, Suzui M, Vural ME, Xiao D, Weinstein IB. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res. 8: 893-903 (2002).
19. Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A, Salguero PMF. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-κB. Int. J. Cancer 115: 74-84 (2005).
20. Yang F, Oz HS, Barve S, De Villiers WJS, McClain CJ, Varilek GW. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-κB activation by inhibiting IκB kinase activity in the intestinal epithelial cell line IEC-6. Mol. Pharmacol. 60: 528-533 (2001).
21. Gupta S, Hastak K, Afaq F, Ahmad N, Mukhtar H. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor κB and induction of apoptosis. Oncogene 23: 2507-2522 (2004).
22. Syed DN, Afag F, Kweon M, Hadi N, Bhatia N, Spiegelman VS, Mukhtar H. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-κB activation in normal human bronchial epithelial cells. Oncogene 26: 673-682 (2007).
23. Shishodia S, Majumdar S, Banerjee S, Aggarwal BB. Ursolic acid inhibits nuclear factor-κB activation induced by carcinogenic agents through suppression of IκBα kinase and p65 phosphorylation: Correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res. 63: 4375-4383 (2003).
24. Nguyen TTT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis 25: 647-659 (2004).
25. Kuo P, Liu H, Chao J. Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells. J. Biol. Chem. 279: 55875-55885 (2004).
26. Culpitt SV, Rogers DF, Fenwick PS, Shah P, De Matos C, Russel REK, Barnes PJ, Donnelly LE. Inhibition by red wine extracts, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 58: 942-946 (2003).
27. Donnelly LE, Newton R, Kennedy GE, Fenwick PS, Leung RHF, Ito K, Russell REK, Barnes PJ. Anti-inflammatory effects of resveratrol in lung epithelial cells: Molecular mechanisms. Am. J. Physiol.-Lung C. 287: L774-L783 (2004).
28. Lee J, Im Y, Jung HH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, Park YS, Kang WK, Park K. Curcumin inhibits interferon-α induced NF-κB and COX-2 in human A549 non-small cell cancer cells. Biochem. Bioph. Res. Co. 334: 313-318 (2005).
29. Biswas SK, McClure D, Jimenez LA, Megson IL, Rahman I. Curcumin induces glutathione biosynthesis and inhibits NF-κB activation and interleukin-8 release in alveolar epithelial cells: Mechanism of free radical scavenging activity. Antioxid. Redox Sign. 7: 32-41 (2005).
30. Eberhardt MV, Lee CY, Liu RH. Antioxidant activity of fresh apples. Nature 405: 903-904 (2000).
31. Gerhauser C. Cancer chemopreventive potential of apples, apple juice, and apple components. Planta Med. 74: 1608-1624 (2008).
32. Knekt P, Järvinen R, Seppänen R, Heliövaara M, Teppo L, Pukkala E, Aromaa A. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am. J. Epidemiol. 146: 223-230 (1997).
33. Le Marchand L, Murphy SP, Hankins JH, Wilkens LR, Kolonel LN. Intake of flavonoids and lung cancer. J. Natl. Cancer Inst. 92: 154-160 (2000).
34. Feskanich D, Ziegler RG, Michaud DS, Giovannucci EL, Speizer FE, Willett WC, Colditz GA. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J. Natl. Cancer Inst. 92: 1812-1823 (2000).
35. Sun J, Chu Y, Wu X, Liu RH. Antioxidant and antiproliferative activities of common fruits. J. Agr. Food Chem. 50: 7449-7454 (2002).
36. Yoon H, Liu RH. Effect of selected phytochemicals and apple extracts on NF-κB activation in human breast cancer MCF-7 cells. J. Agr. Food Chem. 55: 3167-3173 (2007).
37. Liu RH, Liu J, Chen B. Apples prevent mammary tumors in rats. J. Agr. Food Chem. 53: 2341-2343 (2005).
38. Wolfe K, Wu X, Liu RH. Antioxidant activity of apple peels. J. Agr. Food. Chem. 51: 609-614 (2003).
39. Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A, Salguero PMF. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-κB. Int. J. Cancer 115: 74-84 (2005).
40. Janssen YMW, Sen CK. Nuclear factor κB activity in response to oxidants and antioxidants. Method. Enzymol. 300: 363-374 (1999).
41. Nakajima H, Nagaso H, Kakui N, Ishikawa M, Hiranuma T, Hoshiko S. Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-κB-dependent gene expression in primary cultured mouse glial cells. J. Biol. Chem. 279: 42774-42786 (2004).
42. Liu RH, Jacob J, Tennant B. Chemiluminescent detection of protein molecular weight markers in western blot techniques. Biotechniques 22: 594-595 (1997).
43. Place RF, Noonan EJ, Giardina C. HDAC inhibition prevents NF-κB activation by suppressing proteasome activity: Down-regulation of proteasome subunit expression stabilizes IκBα. Biochem. Pharmacol. 70: 393-406 (2005).
44. Perkins ND. NF-κB: Tumor promoter or suppressor? Trends Cell. Biol. 14: 64-69 (2004).
45. Lee HH, Dadgostar H, Cheng Q, Shu J, Cheng G. NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. P. Natl. Acad. Sci. USA 96: 9136-9141 (1999).
46. Viatour P, Bentires-Alj M, Chariot A, Deregowski V, De Leval L, Merville M, Bours V. NF-κB2/p100 induces Bcl-2 expression. Leukemia 17: 1349-1356 (2003).
47. Tergaonkar V, Pando M, Vafa O, Wahl G, Verma I. p53 stabilization is decreased upon NF-κB in acquisition of resistance to chemotherapy. Cancer cell 1: 493-503 (2002).
48. De Bettignies G, Coux O. Proteasome inhibitors: Dozens of molecules and still counting. Biochimie 92: 1530-1545 (2010).
49. He X, Liu RH. Triterpenoids isolated from apple peels have potent antiproliferative activity and may be partially responsible for apple's anticancer activity. J. Agr. Food Chem. 55: 4366-4370 (2007).